Logo
    Search

    About this Episode

    MMC adviser and Head of Business Development at Current Health, Tom Moon, goes 'Beyond the Hype' with Chris McCann, CEO and Co-Founder at Current Health. Current Health is an MMC portfolio company, using the power of artificial intelligence to provide remote patient monitoring. They discuss how Chris came to launch Current Health, the challenges the healthcare industry will face if they don't make make it more efficient and the role of AI in the shift to at home patient care from hospital only care.

    Recent Episodes from Beyond The Hype

    S04E04. Powering your financial wellness

    S04E04. Powering your financial wellness
    MMC Partner Ollie Richards, interviews Stuart Cash, founder and CEO of Y TREE - an MMC portfolio company that combines data, technology and human experience to provide financial life intelligence. Ollie and Stuart discuss the importance of co-founders and first hires, raising institutional capital and the resulting expectations, as well as tips for managing your own money. Listen to the conversation now.

    S04E03. Using data and AI to drive better decision-making

    S04E03. Using data and AI to drive better decision-making
    MMC Partner, Simon Menashy, interviews David Benigson, founder and CEO of Signal AI - an MMC portfolio company that helps companies make informed decisions with artificial intelligence allowing businesses to get ahead of risks, threats, issues and opportunities. David and Simon discuss how the company went from David's parents garage to one of the world’s fastest-growing applied AI companies, the power in the combination of discriminative and generative AI and what this means for Signal AI and the industry as a whole. Listen to the conversation now.

    S04E02. Accelerating the future of personalised medicine

    S04E02. Accelerating the future of personalised medicine
    MMC Principal, Charlotte Barttelot, leads our focus on data-driven health investments. In this episode, she interviews Patrick Short, founder and CEO of Sano Genetics - an MMC portfolio company that connects patients directly with biotech and pharmaceutical companies, accelerating research on rare and chronic diseases. The dramatic reduction of cost and time to sequence the human genome has led to the acceleration of personalised medicine. Charlotte and Patrick discuss the impact this has on the evolution of the drug development process, the change in attitude to the use of personal data, and how important the move towards greater trust and transparency in the industry is.

    S04E01. Cash, capital and costs: Building a transformational business in treasury management

    S04E01. Cash, capital and costs: Building a transformational business in treasury management
    In this episode MMC Partner, Ollie Richards, sits down with Kevin Cook, founder and CEO of TreasurySpring - an MMC portfolio company helping firms of all sizes unlock and protect the true value of their cash assets. Ollie and Kevin discuss what is like to build a business in “one of the least innovative corners of the financial markets” and convince investors and employees to join you on the journey. And, having raised a $29 million Series B led by Balderton Capital in the summer of 2023, Kevin shares insights on business building why it was so crucial that the business could scale in a capital efficient way. Listen to the full conversation now.

    S03E09. The Future of Synthetic Media

    S03E09. The Future of Synthetic Media
    In this episode MMC Partner, Mina Samaan, sits down with Victor Riparbelli, founder of Synthesia - an MMC portfolio company that uses artificial intelligence to create high-end videos for many applications including personalised advertising, corporate communications and e-learning across more than 60 languages. Mina and Victor discuss the company’s recent $50m Series B, what it’s like to work with Snoop Dogg, David Beckham and Lionel Messi, Synthesia’s company culture and how they have retained all but one of their staff since inception.

    S03E07. Machine Learning in the Database

    S03E07. Machine Learning in the Database
    In this episode, MMC Principal Alexia Arts talks to Adam Carrigan and Jorge Torres founders of MindsDB. An MMC portfolio company that helps organisations use machine learning and artificial intelligence to obtain predictive insights that can allow them to make better business decisions. They discuss  why they're on a mission to democratise machine learning, the role that AI plays in their business and what differentiates them from the competition.

    S03E06. Supercharging your Digital Workforce

    S03E06. Supercharging your Digital Workforce
    In this episode, MMC Principal Mina Samaan talks to Erik Lien CEO of RPA Supervisor. An MMC portfolio company that is a Automation Management Platform, keeping bots operating as they encounter common issues. They discuss what led them to launch RPA Supervisor, why it is important to bring in an NED and their most recent round of fundraising.

    S03E05. Role of Tech in Reversing Type 2 Diabetes

    S03E05. Role of Tech in Reversing Type 2 Diabetes
    In this episode, MMC Manager Dele Akinyemi talks to Ian Braithwaite and Napala Pratini co-founders of Habitual. An MMC portfolio company that is a digital-first diabetes prevention and reversal programme that delivers lifelong weight loss and behaviour change. They discuss why they're on a mission to change diabetes type 2 as we know it, the role technology plays in their business and what differentiates them from the competition.

    S03E04. Powering your Financial Wellbeing

    S03E04. Powering your Financial Wellbeing
    In this episode, MMC Managing Partner, Bruce Macfarlane, talks to Richard Wilson, CEO of Interactive Investor, an MMC portfolio company that is the UK's second largest direct to consumer investment platform. They discuss the transition from non-executive to the CEO role, the benefits and challenges of acquiring your competitors, and the impact of the Covid-19 pandemic on the growth of the businesses.